Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 1,079 $ 5,672
Short-term investments 12,893 10,836
Prepaid expenses and other current assets 84 54
Total Current Assets 14,056 16,562
Operating lease right-of-use asset 53 165
Deposits 9
TOTAL ASSETS 14,109 16,736
Current liabilities    
Accounts payable 4,328 3,140
Accrued expenses 1,195 1,669
Current operating lease liability 58 110
Warrant liability 1,052 19
Total Current Liabilities 6,633 4,938
Non-current operating lease liability 64
Total Liabilities 6,633 5,002
Stockholders’ Equity    
Convertible Preferred stock, par value $0.01, 15,000,000 shares authorized, Series C - 96,230 shares issued and outstanding at December 31, 2023 and 2022, respectively 1 1
Common stock, par value $0.001, 250,000,000 shares authorized, 1,380,633 shares and 1,090,748 shares issued and outstanding at December 31, 2023 and 2022, respectively 1 33
Additional paid in capital 689,539 686,168
Accumulated deficit (682,065) (674,468)
Total Stockholders’ Equity 7,476 11,734
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 14,109 $ 16,736